Smith & Nephew PLC ADR (SNN): Price and Financial Metrics

Smith & Nephew PLC ADR (SNN): $30.08

-0.21 (-0.69%)

POWR Rating

Component Grades








Add SNN to Watchlist
Sign Up

Industry: Medical - Devices & Equipment




#3 of 140

in industry

SNN Price/Volume Stats

Current price $30.08 52-week high $33.08
Prev. close $30.29 52-week low $21.77
Day low $29.90 Volume 505,000
Day high $30.26 Avg. volume 850,232
50-day MA $30.59 Dividend yield 2.99%
200-day MA $27.31 Market Cap 13.14B

SNN Stock Price Chart Interactive Chart >


  • Sentiment is the dimension where SNN ranks best; there it ranks ahead of 93.73% of US stocks.
  • The strongest trend for SNN is in Growth, which has been heading up over the past 179 days.
  • SNN ranks lowest in Quality; there it ranks in the 57th percentile.

SNN Stock Summary

  • SMITH & NEPHEW PLC's market capitalization of $13,274,449,973 is ahead of 86.94% of US-listed equities.
  • With a one year PEG ratio of 2,619.17, SMITH & NEPHEW PLC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.93% of US stocks.
  • SNN's current price/earnings ratio is 59.53, which is higher than 90.6% of US stocks with positive earnings.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SMITH & NEPHEW PLC are SCPL, CCJ, PNR, EBMT, and ATKR.
  • Visit SNN's SEC page to see the company's official filings. To visit the company's web site, go to

SNN Valuation Summary

  • SNN's price/sales ratio is 2.6; this is 18.18% higher than that of the median Healthcare stock.
  • SNN's price/earnings ratio has moved up 48.6 over the prior 243 months.

Below are key valuation metrics over time for SNN.

Stock Date P/S P/B P/E EV/EBIT
SNN 2023-05-23 2.6 2.6 60.9 51.1
SNN 2023-05-22 2.7 2.6 62.3 52.1
SNN 2023-05-19 2.7 2.7 62.7 52.4
SNN 2023-05-18 2.7 2.7 63.2 52.7
SNN 2023-05-17 2.7 2.7 64.0 53.3
SNN 2023-05-16 2.7 2.7 64.0 53.3

SNN Growth Metrics

    Its year over year net cashflow from operations growth rate is now at 7.82%.
  • Its 5 year net cashflow from operations growth rate is now at 32.37%.
  • The year over year net income to common stockholders growth rate now stands at 16.96%.
SNN's revenue has moved up $77,000,450 over the prior 30 months.

The table below shows SNN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 5,215 581 223
2022-06-30 5,212 1,048 524
2021-12-31 5,212 1,048 524
2021-12-31 5,212 1,048 524
2021-06-30 4,560.001 972.0003 448.0001
2020-12-31 4,560 972 448

SNN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNN has a Quality Grade of B, ranking ahead of 77.5% of graded US stocks.
  • SNN's asset turnover comes in at 0.445 -- ranking 108th of 186 Medical Equipment stocks.
  • HOLX, TTOO, and BIOL are the stocks whose asset turnover ratios are most correlated with SNN.

The table below shows SNN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.445 0.694 0.050
2020-12-31 0.449 0.694 0.051
2020-12-31 0.449 0.694 0.051
2020-06-27 0.556 0.740 0.146
2019-12-31 0.592 0.740 0.174
2019-12-31 0.592 0.740 0.174

Smith & Nephew PLC ADR (SNN) Company Bio

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. (Source:Wikipedia)

SNN Latest News Stream

Event/Time News Detail
Loading, please wait...

SNN Latest Social Stream

Loading social stream, please wait...

View Full SNN Social Stream

Latest SNN News From Around the Web

Below are the latest news stories about SMITH & NEPHEW PLC that investors may wish to consider to help them evaluate SNN as an investment opportunity.

Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digital surgery portfolio – Personalized Planning powered by AI and RI.INSIGHTS Data Visualization Platform.

Yahoo | May 16, 2023

Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces its PICO Single Use Negative Pressure Wound Therapy Systems have received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of the PICO Single Use Negative Pressure Wound Therapy Systems by hospital experts who serve on one of Vizient's member-led councils, and it signifies

Yahoo | May 2, 2023

Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Yahoo | April 25, 2023

Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets surgeons measure the ligament tension in a knee prior to cutting bone.1 By enabling a surgeon to quantify joint laxity in the native knee and achieve an optimal ligament tensioning force, the CORI Digital Tensioner helps to reduce variability when balancing the knee in surgery.1-4 This helps make surgical planning more objective versus other

Yahoo | April 24, 2023

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | April 14, 2023

Read More 'SNN' Stories Here

SNN Price Returns

1-mo -4.66%
3-mo 6.58%
6-mo 12.67%
1-year -1.34%
3-year -24.98%
5-year -9.57%
YTD 13.72%
2022 -20.26%
2021 -16.26%
2020 -10.45%
2019 30.78%
2018 8.84%

SNN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SNN Dividend History

Continue Researching SNN

Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:

Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!